Omkar Speciality Chemicals Monitoring Committee meets on May 27
Omkar Speciality Chemicals Limited's Monitoring Committee will meet on May 27, 2026, to approve unaudited financials for the quarters ended June, September, and December 2025. The agenda includes appointing an Independent Director, a CEO, and auditors, as well as constituting board committees. The committee will also discuss CIRP costs and the refund of Performance Bank Guarantee.
*this image is generated using AI for illustrative purposes only.
Omkar Speciality Chemicals Limited has announced that its Monitoring Committee will convene on May 27, 2026. The meeting is being held pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company is currently under the Corporate Insolvency Resolution Process (CIRP) following an order dated December 5, 2022.
Agenda for the Meeting
The primary focus of the meeting will be the review and approval of the company's unaudited financial statements. The committee is set to consider the financial results for three specific quarters ending June 30, 2025, September 30, 2025, and December 31, 2025.
Key Appointments and Committees
Beyond financial approvals, the committee will deliberate on several governance and operational matters. This includes the constitution of the Audit Committee of the Board and the Stakeholder's Relationship Committee of the Board. The meeting will also see the appointment of Mr. Ruhini Kumar Chakraborty (DIN: 08124270) as an Independent Director and Mr. Dipak Kumar Shaw (PAN: CCYPS8421F) as the Chief Executive Officer (CEO) of the company.
Administrative and Financial Resolutions
The agenda further includes administrative decisions critical to the company's operations. The Monitoring Committee will consider the appointment of Statutory Auditors to fill a casual vacancy and the appointment of a Secretarial Auditor for the Financial Year 2025-26. Additionally, the committee will discuss the opening of a current bank account with ICICI Bank.
CIRP Related Discussions
The meeting will also address specific matters related to the ongoing insolvency proceedings. The committee is scheduled to discuss the CIRP costs and the refund of Performance Bank Guarantee (PBG). These discussions are part of the broader resolution efforts for Omkar Speciality Chemicals Limited.
| Agenda Item | Details |
|---|---|
| Financial Statements | Unaudited results for Q1, Q2, and Q3 FY 2025-26 |
| Committee Constitution | Audit Committee and Stakeholder's Relationship Committee |
| Director Appointment | Mr. Ruhini Kumar Chakraborty (Independent Director) |
| CEO Appointment | Mr. Dipak Kumar Shaw |
| Auditor Appointments | Statutory Auditors and Secretarial Auditor for FY 2025-26 |
| Bank Account | Opening of current account with ICICI Bank |
| CIRP Matters | Discussion on CIRP Cost and refund of PBG |
What are the key financial metrics expected to emerge from the three-quarter unaudited results, and could they signal a viable path toward resolution of Omkar Speciality Chemicals' insolvency?
How might the appointment of a new CEO and Independent Director influence the company's operational strategy and attractiveness to potential resolution applicants under the CIRP process?
Given that the CIRP was initiated in December 2022, what are the regulatory implications if the insolvency resolution process extends beyond the statutory timeline, and how could this affect creditors?
17
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
